Harte Hanks (HHS) Shares Outstanding (Weighted Average) (2010 - 2026)

Harte Hanks (HHS) has 17 years of Shares Outstanding (Weighted Average) data on file, last reported at $7.4 million in Q1 2026.

• Shares Outstanding (Weighted Average) for Q1 2026 came in at $7.4 million, up 0.76% year-over-year; the trailing twelve-month figure through Mar 2026 was $7.4 million (up 0.76% YoY), and the FY2025 annual result was $7.4 million, up 1.37% from the prior year.
• Shares Outstanding (Weighted Average) held at $7.4 million in Q1 2026 per HHS's latest filing, from $7.4 million in the prior quarter.
• Over five years, Shares Outstanding (Weighted Average) peaked at $7.4 million in Q1 2023 and troughed at $7.0 million in Q1 2022.
• A 5-year average of $7.3 million and a median of $7.3 million in 2024 frame the typical range for Shares Outstanding (Weighted Average).
• The sharpest annual moves came in 2023 and 2024: Shares Outstanding (Weighted Average) gained 6.21% in 2023, then retreated 2.55% in 2024.
• A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $7.1 million in 2022, then grew by 2.94% to $7.3 million in 2023, then retreated by 0.23% to $7.3 million in 2024, then climbed by 1.37% to $7.4 million in 2025, then advanced by 0.31% to $7.4 million in 2026.
• Business Quant data shows HHS's Shares Outstanding (Weighted Average) at $7.4 million in Q1 2026, $7.4 million in Q4 2025, and $7.4 million in Q3 2025.